Myosin VI is an unconventional Myosin that has been implicated in vesicle transport and membrane trafficking. We isolated lethal mutants of Myosin VI, which lack protein once maternal supplies have been utilised during embryogenesis. Dorsal closure, where there is a ring of Myosin VI at the edge of the migrating epithelial sheet, is often abnormal. The sheet of migrating cells is irregular, rather than a smooth epithelium and cells begin to detach. Some embryos hatch into larvae, containing detached cells loose in the haemolymph. Myosin VI is crucial for correct cell morphology and maintenance of adhesive cellular contacts within epithelial cell layers.
Introduction
Unconventional myosins are motor proteins that move along actin filaments. There are many classes of myosins in this superfamily and they have been identified in a wide variety of organisms. The head domains are well conserved and contain the motor, ATP and actin-binding domains that allow the protein to move. The tails vary dramatically between classes of myosins and often carry cargoes. Myosins play a variety of roles in organelle, RNA and protein transport, cell movements, signal transduction, maintaining the morphology of cells, and membrane trafficking (Wu et al., 2000; Oliver et al., 1999; Baker and Titus, 1998; Mermall et al., 1998) .
In mammals Myosin VI is encoded by the mouse Snell's Waltzer deafness gene (Hasson and Mooseker, 1994; Avraham et al., 1995 Avraham et al., , 1997 . The protein is thought to be necessary for anchoring the stereocilia membrane into the cuticular plate of the inner ear (Avraham et al., 1995; Hasson et al., 1997) . This region is active in transporting vesicles to the apical surface of cells. It would seem that in the mouse, without Myosin VI the structural integrity of hair cells is lost, leading to a loss of hearing. The connection between hearing loss and Myosin VI was found also in humans, where patients suffering from a non-syndromic dominant form of deafness (NSAD), were found to have a missense mutation in the human Myosin VI gene, MYO6 (Melchionda et al., 2001; Ahmed et al., 2003; Mohiddin et al., 2004) . In rat brain, Myosin VI interacts with SAP97, a member of the MAGUK (membrane-associated guanylate kinase homologue) family, which plays a role in synaptic localisation and membrane trafficking of GluR1, a subunit of a-amino-3-hydroxy-5-methylsoxazole-4-propionic acid (AMPA)-type glutamate receptors. It seems that Myosin VI translocates AMPA receptors via connection to SAP97 to and from postsynaptic plasma membranes (Wu et al., 2002) .
Myosin VI has been shown to be associated with the Golgi complex and the leading edge of the cell. In cultured rat and human cells Myosin VI is specifically phosphorylated and then translocated to the ruffles that form as the cells move (Buss et al., 1998) . Furthermore, Myosin VI associates with the adaptin complex on clathrin-coated vesicles (Buss et al., 2001) , and with Disabled 2 (DAB2), which connects Myosin VI to clathrin coated pits (Morris et al., 2002) . These results suggest that Myosin VI has a key role in membrane trafficking, both in secretion and endocytosis.
Myosin VI (Myosin 95F) is encoded in Drosophila by the jaguar ( jar) gene (Hicks et al., 1999) . It has been shown to be expressed at a variety of developmental stages and is essential for several developmental events Lantz and Miller, 1998; Deng et al., 1999) . A partial loss of function mutant causing male sterility demonstrated a key role for Myosin VI in sperm individualisation (Hicks et al., 1999) . In the testes Myosin VI interacts with Cortactin and the Arp2/3 complex, which is necessary for regulation of actin polymerisation, and also with Dynamin, a protein promoting the transition of clathrin-coated pits into clathrin-coated vesicles (Rogat and Miller, 2002) . It is proposed that Myosin VI is important for the assembly of actin filaments in the region where membranes are assembled within the individualization complex, during sperm morphogenesis. Myosin VI is also essential in C. elegans spermatogenesis, where it is involved in the unequal distribution of organelles and cytoskeletal components during the formation of the Residual body and the budding spermatids (Kelleher et al., 2000) .
During oogenesis Myosin VI is required for all the cell migrations undertaken by the follicle cells. By interfering with Myosin VI expression using an antisense RNA in vivo, the formation of the follicle cell epithelium by the columnar and centripetal cells was disrupted . Recently it has been shown that the migration of the border cells is disrupted when the expression of Myosin VI is blocked, and that the migration is coordinated with E-cadherin and Armadillo (Geisbrecht et al., 2002) . Deng et al. (1999) also showed that Myosin VI was needed for epithelial morphogenesis at a variety of developmental stages. Using inhibition of Myosin VI by antibody injection it was shown that the invaginations of membranes needed for blastoderm cell formation in the embryo required Myosin VI (Mermall et al., 1994; Mermall and Miller, 1995) . Using a similar method Myosin VI has been shown to be important for transport of material from the nurse cells to the oocyte during oogenesis (Bohrmann, 1997) .
Finally, since the work in this paper was completed Myosin VI was found to interact with Miranda. Myosin VI is necessary for the basal localisation of Miranda, and for spindle orientation in the metaphase neuroblast. In homozygous null mutant embryos, jar 322 , Miranda is mislocalized to cortical patches and to the cytoplasm rather than the basal crescent of the metaphase neuroblast and the spindle was misorientated (Petritsch et al., 2003) .
We demonstrate, using newly isolated mutants, that Myosin VI is crucial for viability and maintenance of cells in epithelial cell layers.
Results
We have generated lethal mutants of the jar gene encoding Myosin VI. They die as late embryos and larvae. The mutants are shown to lack Myosin VI by antibody staining of embryos and by Western blotting. Mutant embryos survive well into embryogenesis using the supply of maternally stored mRNA but in later stages specific transcripts are depleted. When the epithelial sheets migrate during normal dorsal closure they express a tight Myosin VI band at the moving front. The mutants lack this Myosin VI band and fold inside the embryos, some cells are loose and begin to detach from the epithelium and embryos frequently fail to complete dorsal closure. Similar results were obtained when a Myosin VI dominant negative was expressed.
Isolation of new jar mutants
Previous mutant screens in our laboratory had generated a male sterile mutation in the jar gene which encodes Myosin VI. The jar mmw14 mutant lacks transcripts in the testis, but generates transcripts in other tissues and at other developmental stages (Hicks et al., 1999) , due to a deletion of non-coding exon 1 (Fig. 1C) . To generate further mutants we used a similar strategy and remobilised a gal4 insertion in the jar gene (C865). Fig. 1A shows the intron-exon organisation of jar, which we determined by sequence analysis and by using the published Drosophila genome sequence (Adams et al., 2000) .
Mutations were created by remobilising the P element insertion line C865 and 480 new lines were established. Five red-eyed lines were homozygous lethal. Two of the red-eyed lines jar R23 and jar R70 failed to complement the deficiency line for the jar region, Df87-5, resulting in embryonic lethality. Two other red-eyed lines, jar R39 and jar R235 failed to complement the mutant jar mmw14 resulting in male sterility. The complementation tests along with the protein expression analysis (described in the following section) suggests that all the four lines are homozygous lethal due to mutations in the jar gene.
Molecular analysis of jar
R39 and jar R235 mutants
The P element in the C865 line which was used for the P hop mutagenesis is located in the 5 0 UTR of jar mRNA (Fig. 1B) . When we undertook PCR with primers flanking the location of the original P element location, we found that the P element was excised from the 5 0 UTR region in all the mutants, jar R23 , jar R39 , jar R70 and jar R235 (Fig. 2) . jar
R39
and jar R235 were the mutants that showed the most severe phenotypes, therefore we decided to determine the molecular basis of the mutations in these lines. The details of how this was undertaken are presented in the Materials and Methods. As the alternations were small, they were established by sequencing the mutant DNA in the region deleted in jar mmw14 mutants. This revealed that in the jar R39 /jar mmw14 heterozygotes the sequence: GTA TAC0TG (347 -340 bp upstream of the first exon) was deleted, while the sequence: TTTATATATACTGA-TATG (341-322 bp upstream of the first exon) was duplicated (Fig. 1D) . In jar R235 /jar mmw14 the sequence: GTATAC (347 -342 bp upstream to the first exon) was changed to: GTTTTC, possibly by deletion of the sequence: ATA and duplication of the sequence: TTT (341 -339 bp upstream of the first exon, see Fig. 1E ). This mutation is located in the same region as the mutation in jar R39 and explains why the two new mutant lines fail to complement each other. jar R235 also has a missing nucleotide, A, 438 bp upstream of the first exon (Fig. 1E) , and the nucleotide G (38 bp upstream of the first exon) was replaced by A (Fig. 1E) .
In spite of the excision of the P element from the 5 0 UTR in the two mutants, the flies are red-eyed, therefore a P , a pair of primers were designed to replicate the whole deletion region. In that way, only the mutant genomic DNA was amplified by PCR, and the specific mutation (marked by a red asterisk) was located in this region by sequencing. : the sequence GTATAC was changed to GTTTTC, the nucleotide A, 438 bp upstream to the first exon was deleted, and the nucleotide G (38 bp upstream to the first exon) was replaced with an A. element must have been inserted into a different region of the genome. Inverse PCR revealed that in jar R39 a P element has inserted into the third chromosome, within the hypothetical gene CG5991, upstream of jar. The P element in jar R235 was also re-inserted into the third chromosome, upstream of jar, in a region between the hypothetical genes: CG6164 and CG 6173. The two new jar mutants fail to complement each other and the deletion mutant jar mmw14 but we needed to be sure that the lethality associated with jar R39 /jar R235 trans-heterozygous embryos and larvae are due to the mutations in Myosin VI and not in the other genes where the P element has inserted. We investigated the expression of Myosin VI and analysed the phenotype of the trans-heterozygous mutant jar R39 /jar R235 . Because the insertion sites of the P element in jar R39 and jar R235 are different, the cross of the two mutants will complement any mutations caused by the re-insertion of chromosome 3, allowing us to test the phenotype of the mutations within jaguar only. The transheterozygous mutants had a similar phenotype to the homozygous mutants: i.e. Myosin VI was absent late in embryogenesis and many embryos failed to complete dorsal closure (Fig. 5E -I ). Those which completed dorsal closure died during the first larval instar. Thus we can attribute the phenotypes to a deficiency in Myosin VI late in embryogenesis.
The transcription of the 5
0 end of the mRNA is disrupted in homozygous mutants
Previously it was shown that jar mmw14 mRNA is disrupted in the 5 0 region: up to 517 nucleotides are not transcribed at the 5 0 end of the mRNA (Hicks et al., 1999) . Since jar mmw14 does not complement jar R39 or jar R235 we wanted to test if transcription is also disrupted in these mutants. RTPCR was undertaken, using RNA templates from homozygous mutant and OrR larvae (1st instar), for two regions at the 5 0 end of the jar mRNA: the first 1027 nucleotides and the region between nucleotides 517 and 1027 were investigated (Fig. 3A ). An additional RTPCR was made for a region located further downstream, 2850-4100 bp from the 5 0 end. The RTPCR of the two 5 0 regions was very weak in the homozygous mutant larvae, compared to OrR larvae (Fig. 3B ). It seems that as in jar mmw14 , there is reduced transcription of jar mRNA at the 5 0 end in jar R39 and jar R235 mutants. When RTPCR undertaken at the 3 0 end (Fig. 3C ), a high level of product was observed, although not to the same level as in OrR. This is to be expected since transcripts initiated at the 5 0 end of the gene are absent. This suggests that only some of the transcripts are affected. When RTPCR was made for mRNA of ribosomal protein (Fig. 3D ) and myosin 29D (Fig. 3E) as a control, the expression level in the homozygous mutants was similar to the expression in OrR, therefore the disruption in mRNA expression is unique to jar. Given that there are at least some transcripts present in larvae in the jar R39 and jar R235 it seems unlikely either are nulls.
Mutants lack or have reduced myosin VI protein
We next tested if these mutations led to a reduction or loss of Myosin VI expression during embryogenesis, since studies of the mutants indicated that they died as late embryos and during early larval development. Since there is a supply of maternal mRNA we collected late embryos, and analysed them by Western blotting. We used the yolk proteins as a loading control. The results in Fig. 3F show that wild type OrR and jar mmw14 embryos have high levels of several isoforms of Myosin VI. jar R23 has slightly reduced Myosin VI, jar R70 has much reduced Myosin VI and in jar R39 and jar R235 no Myosin VI could be detected by Western blotting. This demonstrated that two of the mutants we had isolated affected the expression of Myosin VI in late embryogenesis dramatically. Taken together with the complementation analysis and our molecular studies these two mutants are identified as jar mutants and have thus been called jar R39 and jar R235 . Using Myosin VI antibody the temporal and spatial distribution of Myosin VI protein was analysed in wild type and homozygous mutant embryos. Myosin VI could be seen in the forming blastoderm cells. This was observed in both wild type and mutant embryos and reflects the stored /TM3, jar R235 /TM3, in C865and in OrR, using primers flanking the insert region: C865For and C865Rev. In C865 two bands appeared: the upper band (arrow) corresponds to the P element, 14 kb, and the lower band corresponds to the same region in the chromosome that does not contain the P element (as in OrR). In all the mutants, the P element band is not detected indicating that the P element was excised from the 5 0 UTR.
component of maternal Myosin VI (data not shown).
Once the embryo begins to develop Myosin VI is seen in many cells. In OrR flies, Myosin VI expression is strong during germ band extension ( Fig. 4A ) and during dorsal closure there is a very tight ring of expression in the cells migrating to close the gut (Fig. 4B) , and a strong expression of myosin VI is observed along the apical side of the cells at the leading edge (Fig. 4D ). There are two patches of expression of Myosin VI in the posterior of the larva and late embryo possibly in the posterior spiracle ( Fig. 4C ). In the mutants, by the time dorsal closure commences there is no detectable Myosin VI ( Fig. 4E ) and this loss of Myosin VI continues into the fully formed larvae (Fig. 4F ). Myosin VI was also below detectable levels in late embryos of heteroallelic mutants jar R39 /jar R235 (Fig. 4G ). 0 region of jar mRNA, using the primers p1 þ p1027, and p517 þ p1027. In jar R39 and jar R235 the PCR gave a signal which is much weaker compared to OrR, suggesting that these transcripts are not synthesized in the larvae and the weak signal obtained was probably from remaining maternal transcripts. . In each case there is yolk protein present to show that similar numbers of embryos were loaded on the tracks. The three bands near Myosin VI correspond to the three isoforms bearing molecular weights of 120, 140 and 145 kDa, and the three lines near the YP correspond to the yolk polypeptides YP1, YP2, and YP3, having a molecular weight of 47, 46 and 45 kDa, respectively.
Myosin VI is necessary for dorsal closure and germ band retraction
Most homozygous mutant embryos developed into late embryos which failed to hatch. A few hatched into larvae, but soon died. The anterior/posterior and dorsal/ventral polarity and segment number was normal. A number of embryos failed to complete dorsal closure and thus there was exposed yolk and free floating yolk between the cuticle and the vitelline membrane and many embryos had loose cells inside the vitelline membrane. The cells in the amnioserosa were detached. The leading edge of the epithelial sheets lost their tight and organised shape (Figs. 5E -I), and the tissue was folded inside.
In some of embryos the germ band remained elongated and detached from the amnioserosa, indicating that germ band retraction was incomplete (Fig. 5H -I) . Many of the mutant embryos that died and larvae that hatched had completed dorsal closure but had loose cells floating in the haemolymph in the dorsal aorta. These were best visualised in living embryos. dominant negative, DATP-jar (Fig. 7) . When DATP-jar was expressed by engrailed-gal4 (en-gal4) at the posterior stripes of each segment, the tissue was ruptured, the cells at the leading edge and in the amnioserosa were detached and in certain areas the two tissues were disconnected (Figs. 7A and 9B) . Embryos that reached the final stages of dorsal closure had holes in the dorsal midline, suggesting that Myosin VI is necessary for the adhesion of the cells at the leading edge and in the amnioserosa and for the adhesion of the opposite leading edges along the dorsal midline, during the final 'zipping' of the epidermis (Fig. 7C) . The changes in cell shape and the tendency of the cells to fold inside in stripes of cells expressing DATP-jar indicates that Myosin VI is involved in maintaining cell shape and rigidity in the lateral epidermis (Fig. 7D,E) . Finally, many embryos failed to complete germ band 
/jar
R35 stained with myosin II antibody. They fail to complete dorsal closure and germ band retraction. In figures E and I the 'purse string' around the amnioserosa is absent and the expression of Myosin II at the leading edge is absent as well, although Myosin II is present in the cells of the lateral epidermis and the amnioserosa. The amnioserosa sheet has lost its organised uniform sheet, having loose cells with a changed shape and holes (arrows). The cells at the leading edge have been folded inside thus it is impossible to observe the actin-myosin cable. The embryos in A-D, H-I are stained with nonmuscle Myosin II. AS ¼ amnioserosa. LE ¼ leading edge.
retraction, leaving the germ band tissue loose and separated from the amnioserosa (Fig. 7F) , and the retraction arrested (Fig. 7G) embryonic lethality. In this experiment, a cross was undertaken between heterozygous flies, to create two groups of mutant embryos: the first group express Myosin VI tagged to GFP (PGM) throughout the embryo; therefore the embryos of this group are fluorescent. The second group, which does not express PGM were non-fluorescent. In every group, 25% of the flies are homozygous mutant (the details of the cross and the corresponding progeny genotypes are described in the Materials and Methods, and summarised in Fig. 8D ). In the non-fluorescent group, many of the homozygous mutant flies will fail to hatch. However, if the expression of PGM rescues the embryos, the number of fluorescent larvae hatching from the eggs will be higher than the number of non-fluorescent larvae. A reciprocal cross was established to test the effect of maternal PGM. As a control, heterozygous flies were crossed with the balancer line TM3/TM6: this cross is expected to create progeny with a similar survival rate in the fluorescent and the non-fluorescent group.
The results are shown in Fig. 8E . In both the control and the experimental groups the survival of fluorescent embryos was slightly higher, but the difference between the survival of fluorescent and non fluorescent embryos in the experimental group was significantly higher, than the control group thus the expression of PGM significantly increased the survival of the mutant embryos. When female fluorescent heterozygous flies were crossed, the embryonic survival was slightly higher than in the reciprocal cross; however, the differences are not significant. The survival rate of all the embryos was lower than the expected presumably due to the manual collection and frequent handling of the embryos, to assess their fluorescence signal. The survival rate of OrR embryos with similar handling is 74% (data not shown). Taken together these results show that the expression of PGM rescues the embryonic lethal phenotype of jar R39 and jar R235 mutants. Therefore the embryonic lethal phenotype results from the disruption in Myosin VI expression.
Disruption of Myosin VI function affects DE-cadherin expression
Epidermal cells expressing of DATP-jar had altered cell adhesion properties. Cell-cell adhesion in the Drosophila embryonic epidermis is mediated by DE-cadherin. Myosin VI was found to interact with DE-cadherin during the migration of border cells during oogenesis (Geisbrecht and Montell, 2002) . This raises the possibility that Myosin VI interacts with cadherin during embryogenesis and that the loss of cell -cell adhesion Myosin VI function is disrupted could lead to changes in DE-cadherin expression or localisation.
Embryos expressing DATP-jar by en-gal4 during dorsal closure were stained with DE-cadherin antibody (Fig. 9A,B) . In some of the embryos, DE-cadherin levels were significantly reduced in cells expressing DATP-jar (Fig. 9A) . In other embryos the localisation of DE-cadherin . A milder version of this phenotype appeared in the mutants (see Fig. 11 ). (F,G): In many cases germ band retraction is not completed, the germ band tissue is loose and folded, and the posterior spiracles are not formed. In (F), the process of dorsal closure was progressed in spite of the incomplete process of germ band retraction (DE-cadherin stain). In (G) germ band retraction ceased in very early stage: the embryo is totally folded, and the germ band tissue is disconnected from the amnioserosa. . Crosses 1 and 2 were the experimental group and crosses 3 and 4 were the control group (see description in the Materials and Methods). Crosses 1 and 3 (the first two columns) were made with heterozygous female mutants expressing PGM protein (fluorescent) and non-fluorescent male. Crosses 2 and 4 were created with fluorescent heterozygous male and non-fluorescent females. The difference between the survival of fluorescent and non-fluorescent embryos was compared between groups 1 and 3, and between groups 2 and 4 and examined statistically with a chi-squared test. The asterisks indicate a significant increase in the survival rate of fluorescent embryos ðP , 0:005Þ: was disrupted and the protein appeared in the cell cytoplasm and not in the cell membrane as in the wild-type cells (Fig. 9B ). In the mutant embryos, the localisation of DE-cadherin in the lateral epidermis, the leading edge and the amnioserosa cells was not altered (Fig. 9C) . It is possible that the maternal Myosin VI leads to the correct localisation of cadherin. Similar results were observed when the expression of DE-cadherin was examined in RhoA homozygous mutant embryos and in embryos expressing the dominant-negative of RhoA, RhoN19: In the homozygous mutant RhoA embryos, no defect was observed in the localisation of DE-cadherin, while the in cells expressing RhoN19 the expression of DE-cadherin was significantly reduced (Bloor and Kiehart, 2002) . In the embryos expressing DATP-jar, the defects observed in the epidermal cells were more severe than the ones observed in the homozygous mutants (possibly due to the maternal contribution of Myosin VI in the mutant embryos).
To test if Myosin VI is also involved in the maintenance of cell shape we examined the effect of Myosin VI on the expression of Myosin II, which is necessary for preserving cell shape at the leading edge and in the amnioserosa during the morphogenic changes of the tissues during dorsal closure (Young et al., 1993) . The expression of Myosin II did not change significantly in the jar R39 and jar R235 mutants, nor in embryos expressing Myosin VI dominant negative (Fig. 5E ,H, and I and unpublished results). These results are consistent with previous studies showing that Myosin VI and Myosin II do not have a physical interaction during embryogenesis (Petritsch et al., 2003) .
Myosin VI is present in the filopodia and lamellipodia during dorsal closure
As the epidermis covers the amnioserosa during dorsal closure, the epithelial cells at the leading edge show extensive activity of filopodia and lamellipodia, which are crucial for zipping together the epithelial sheets and for the precise matching of the cells in the zipping process (Jacinto et al., 2000; Martin and Wood, 2002) . Filopodia and lamellipodia are created through membrane remodelling. The involvement of Myosin VI in the creation of the pseudocleavage furrows in the cyncitial blastoderm (Mermall and Miller, 1995) , and the separating membrane in the stereocilia of the in mice cochlear cells (Avraham et al., 1995; Avraham et al., 1997) raises the possibility that Myosin VI is also involved in the creation of filopodia and lamellipodia at the leading edge. PGM was therefore, expressed during dorsal closure, using an en-gal4 line, and filopodia and lamellipodia were observed in living embryos.
There is strong expression of PGM in the cell membrane at the edge of epithelial cells facing the opposite edge ( Fig. 10A -C, yellow arrows). PGM is also present in filopodia ( Fig. 10A -C, white arrows) and lamellipodia ( Fig. 10D, asterisks) . As the cells meet, PGM expression increases in the adhesion area (Fig. 10B ,C, yellow arrows).
When the adhesion between the cells is completed, the expression of PGM is reduced (Fig. 10E) . The expression of PGM in the filopodia and lamellipodia suggests that Myosin VI is necessary for the migration of the cells as well as for cell adhesion; however the expression in lamellipodia could be necessary for the initial attachment of the cells.
The effect of Myosin VI depletion on actin organisation in the amnioserosa and leading edge cells
Myosin VI was shown to be necessary for the organisation of actin filaments in the individualisation complex in the testes. To test if Myosin VI plays a role in actin dynamics during dorsal closure, actin filaments were stained in mutant embryos with phalloidin. In OrR flies, Myosin VI and actin generally have a similar localisation; however, in the leading edge the actin cable is concentrated mainly around the amnioserosa, whereas the strongest expression of Myosin VI is in a layer of cells between the actin cable and the epithelial sheet (Fig. 11A -C) . In the leading edge the cells are elongated (Fig. 11D) , and connected to the actin cable surrounding the amnioserosa at a uniform width. Not all the mutant embryos showed defects in actin organisation, however in some of the mutant embryos that failed to complete dorsal closure, the actin filaments in the amnioserosa are disassociated (Fig. 11E) . At the leading edge, some regions of the actin cable are destroyed, many of the cells are not elongated and the organisation of the row of cells at the front is disrupted (Fig. 11E) . The aberrant shape of the cells also appears in the border regions between the segments, suggesting that the disruption in cell shape and movement appear not just in the leading edge of the epithelia during dorsal closure, but also in other epithelial cells in the lateral epidermis. When DATP-jar is expressed, the loss in cell shape and actin cable organisation was even more dramatic (Fig. 7 A -C,E) . In severe cases the actin cable disappears, and the cells at the leading edge connect remnants of actin cables that appear as aggregates of filaments (Fig. 7E, arrows) . It seems that cell shape in the leading edge and in the amnioserosa changed significantly as a consequence of loss of cell adhesion. In some embryos the cells at the lateral epidermis changed their shape and the tight organisation of the actin filaments at the cell membrane was disrupted (Fig. 7B) . Therefore the change in the cytoskeletal organisation could be the reason why the cells expressing DATP-jar lose their rigidity and fold in. These results suggest that during dorsal closure Myosin VI plays a role not only in the adhesion of the cells, but also in the arrangement of the actin cytoskeleton.
Discussion
Previous studies showed that in Drosophila Myosin VI plays a role in cell migration during oogenesis Geisbrecht and Montell, 2002) , actin dynamics during . The cells in the amnioserosa lose their organised shape, in the leading edge the actin cable is broken in several places (asterisk), and some of the cells still have a polygonal shape and do not elongate. Note the abnormalities in segment organisation, near the asterisk. sperm individualisation (Hicks et al., 1999; Rogat and Miller, 2002) , membrane synthesis during cellularization (Mermall and Miller, 1995) and spindle orientation in the metaphase neuroblast (Petritsch et al., 2003) . In this study we provide evidence that Myosin VI is necessary for cell -cell adhesion and maintaining cell rigidity during dorsal closure. Disruption in Myosin VI function caused folding-in of the migrating epithelial tissue and rupture of the tissue, which suggests that Myosin VI is necessary not only for the cell -cell adhesion but also for keeping the cells rigid as they migrate.
We have isolated lethal mutants in the jar gene of Drosophila which encodes Myosin VI. The resulting embryos die late in embryogenesis failing to complete dorsal closure or as early larvae. The expression of fluorescent tagged Myosin VI in the mutant embryos rescued the lethal phenotype of embryos indicating that the lethality is caused due to the jaguar mutation.
Genetic and molecular analysis revealed that the two mutants have been disrupted in the sequence: AGTATACT. In jar R235 this sequence has been changed and in jar R39 the sequence is deleted. This is a palindromic sequence and as such could potentially regulate the transcription of jar. In Drosophila palindromic sequences located within the promoter region are often necessary for accurate transcription (Cho et al., 1998; Oh et al., 1999; Okada et al., 2001 ).The palindromic region might be a specific binding site for transcription factors (Hirose et al., 1993) .
Not all the embryos failed to complete dorsal closure and some hatched as larvae. RTPCR results showed that in homozygous mutant embryos (stage 14 onwards) Myosin VI transcripts are still observed. However, in the homozygous mutant larvae, the expression level of Myosin VI transcripts is lower than OrR (these results are consistent with the Western Blot and antibody localization results). These results suggest that survival throughout embryogenesis is due largely to the use of maternal Myosin VI.
In the three mutants: jar mmw14 , jar R39 and jar R235 the 5 0 end of the mRNA was truncated, however the truncated region in jar R39 and jar R235 is bigger than that observed in jar mmw14 (1027 bp compared with 517 bp). This could explain why jar mmw14 mutants survive until adulthood while the jar R39 and jar R235 mutants die during embryogenesis and the first larval instar.
Analysis of the null mutant jar 322 , published after completion of our experiments (Pertrisch et al., 2003) , showed that it affected the embryonic neuroblasts but there is no mention of any defects in cell shape in the lateral epidermis, or of some embryos failing in dorsal closure. However, we have shown that the same dominant negative Myosin VI that caused mislocalisation of Miranda and misorientation of the spindle in neuroblasts is shown to disrupt the cell attachment in the amnioserosa and the leading edge epidermis during dorsal closure. Therefore, Myosin VI is necessary for both neuroblasts morphogenesis and dorsal closure during embryogenesis.
It is surprising to find that the null mutant jar 322 lives until the early stages of second instar, while the homozygous mutants jar R39 and jar R235 die during embryogenesis and during first instar. Since no protein was detected in the mutants jar R39 and jar R235 , the severe effect of the mutants might be expected to be the same as in a null mutant.
Depletion and disruption in Myosin VI function caused detachment of cells and folding-in of the migrating epidermis during dorsal closure. In en-Gal4/DATP-jar embryos these affects were dramatic; if the cells expressing DATP-jar are not as robust as the wild type they might not be able to bear the multiple forces applied to them during dorsal closure, which could lead to the rupture of the tissue caused initially by the detachment of cells.
Cells that express DATP-jar and mutant cells had an aberrant organisation of the actin filaments in the cell cortex at the leading edge, and the cells lost their elongated shape. This is the area that was found to fold-in in many embryos. The connection between the change in cell shape and the disorganisation of the cytoskeleton could suggest that the cytoskeleton is necessary for maintaining cell rigidity. This suggests that Myosin VI preserves cell shape by participating in the synthesis or the patterning of the actin filaments during the migration of the epithelial cells. This is consistent with previous studies showing the role of Myosin VI in actin dynamics in the individualisation complex in the testes (Rogat and Miller, 2002) .
The creation of multiple wounds by laser beams in embryos did not prevent their quick recovery (Kiehart et al., 2000) . Disruption caused by Myosin VI prevents recovery of the ripped tissues, probably due to the loss of cell adhesion properties. This suggests a potentially important role for Myosin VI in wound healing.
The failure in dorsal closure which we observed corresponds well with our antisense experiments during development which led to failures in all the cell migrations of follicle cells during oogenesis. In each case Myosin VI is needed for the correct movement of a sheet or tight cluster of follicle cells K. Leaper and M. Bownes, unpublished) , and in each case the cells lost their shape, therefore Myosin VI might also be needed for the preservation of cell shapes as they migrate. We also observed that the follicle cell layer was disorganised and did not remain as a unicellular sheet . The phenotype is similar in the lethal embryos, where cells detach from sheets and are found loose in the haemolymph and the cells in the leading edge loose their tight organisation. The reduced expression and mislocalisation of DE-cadherin in the follicle cells and the lateral epidermis following the disruption in Myosin VI expression and function support the assumption that Myosin VI might play similar roles in the organisation of the two tissues (Geisbrecht et al., 2002) .
During spermatogenesis in Drosophila male sterile jar mutants fail in sperm individualisation, (Hicks et al., 1999) an event which requires separation of sperm by membranes.
It is possible that Myosin VI also plays a role in the remodelling of cell membranes at the leading edge and that this is crucial for the adhesive properties of the cells during dorsal closure. The presence of Myosin VI in the filopodia and lamellipodia in epithelial cells at the leading edge could be necessary for the remodelling of the cell membrane.
It seems that Myosin VI is crucial for maintaining epithelial sheets and keeping cells in the correct spatial relationship to one another. This could be achieved by Myosin VI anchoring cells to the basement membranes that surround epithelial sheets, or perhaps if Myosin VI is absent from the apical surface of cells, cell polarity is not correctly defined and cell contacts are thus lost.
We need to identify additional potential cargoes carried by the Myosin VI tail by protein -protein interaction experiments in vitro. Although the jar mutants are lethal, we can still investigate the abnormal phenotypes they cause at later developmental stages by producing clones of mutant cells failing to express Myosin VI at various times and in various tissues.
Experimental procedures

Generation of jar mutants and fly crosses
The stocks used in these experiments are: C865 (Deng et al., 1997) ; jar mmw14 (Hicks et al., 1999 .
The jar mutants were generated by mobilising a single P element insertion located in the 5 0 UTR of the jar locus in strain C865, which contains a P element P[GawB] at 95F on the third chromosome (w-; P [Gal4 w þ ] Y; P [Gal4 w þ ]), located at bp 306 in exon 1 (Fig. 1B) Homozygous mutant embryos and larvae were distinguished from their heterozygous siblings by using the fluorescent balancer chromosome Ly 1 /TM6B, GFP Tb. For the expression of dominant negative Myosin VI, virgin female of the en-gal4 line were crossed with male UAS-DATP-jar flies. Statistical analysis used the chi square test ðP , 0:005Þ:
Molecular analysis of mutants
The new mutants jar R39 and jar R235 do not complement the mutant jar mmw14 ( jar mmw14 /jar R39/R235 heterozygotes are male sterile), therefore the mutations were potentially located in the same area as the 1 kb deletion in jar mmw14 (Fig. 1C) . The precise location of the deletion in jar mmw14 was first identified by sequencing jar mmw14 /TM3 heterozygous flies (Fig. 1C) , and the mutations in jar R39 and jar R235 were identified by sequencing the deletion area of jar mmw14 (this contains only the copy of the mutant genes, as shown in Fig. 1C ).
Generation of Myosin VI-GFP (PGM) DNA construct
The DNA construct expressing Myosin VI fused in-frame to Green Fluorescent Protein (GFP) was prepared by two cloning steps. In the first step the 0.8 kb EGFP gene was isolated from pEGFPN1 plasmid (Clontech), using EcoRI and NotI restriction sites, and cloned into a pUAST plasmid (restricted with the same enzymes) to form the pUAST-GFP plasmid. In the second step, a full-length cDNA encoding the EM3 isoform of Myosin VI (95F MHC) was cloned in the pUAST-GFP plasmid, connected in-frame with the EGFP gene at its 3 0 end (see Fig. 8A ). The 4.1 kb Myosin VI cDNA was amplified by proof-reading PCR, with a 5 0 primer that added an EcoRI restriction site upstream of the initiator methionine, and a 3 0 primer, designed to contain AgeI restriction site downstream of the Myosin VI cDNA, and connected in-frame with the EGFP gene.
The proof-reading PCR used the pfu turbo polymerase kit (Stratagene), according to the manufacturer's instructions. The PCR product was digested with EcoRI and AgeI and cloned into the pUAST-GFP plasmid (restricted with the same enzymes), to form the DNA construct: pUAST-Myosin VI-GFP (PGM) DNA construct. The DNA construct was injected into w k fly embryos as described previously . The fly line selected for use in this experiment is PGM 45-1, as the insert is located on the X chromosome.
Mutant rescue
Transgenic flies, containing the Myosin VI cDNA fused in-frame to the EGFP gene (PGM), driven by a UAS (upstream activating sequence) target sequence, were generated by p element-mediated transformation. The PGM transgene was crossed with the e22C-Gal4 line and with the mutant flies jar R39 /TM3, Sb, or jar R235 /TM3 to create the fluorescent heterozygous fly lines: PGM; e22C; jar R39 /TM3, Sb and PGM; e22C; jar R235 /TM3, Sb. e22C fly line express the Gal4 protein ubiquitously during embryogenesis and hence triggers the expression of PGM throughout the embryo during late stages of embryogenesis, when the maternal supplies of Myosin VI begin to disappear. The fluorescent heterozygous flies were crossed with the non-fluorescent heterozygous flies, as described for jar R39 :
4.4.1. PGM; e22C; jar R39 /TM3, Sb X jar R39 /TM3, Sb This cross created fluorescent and non-fluorescent progeny; each group will contain the same genotype composition, as described in the table on Fig. 8D , for the test group. In non-fluorescent flies, because the homozygous mutants are embryonic lethal and the flies homozygous for the balancer chromosome are lethal as well, only the heterozygous embryos are expected to survive, yielding a survival rate of 50%. If the expression of PGM rescues the embryonic lethal phenotype, the fluorescent homozygous embryos will survive and the number of fluorescent larvae hatching from the eggs will be significantly higher than the non-fluorescent embryos. As a control the effect of PGM expression on the survival of embryos which are not homozygous Myosin VI mutants was examined by the following cross (described for jar R39 ):
4.4.2. PGM; e22C; jar R39 /TM3, Sb X TM3, Sb/TM6, Tb This cross created fluorescent and non-fluorescent progeny; each group will contain the same genotype composition, as described in the table in Fig. 8D , for the control group. Each group contains theoretically 75% viable embryos, heterozygous and non-mutant.
In every group a reciprocal cross was established in order to test the maternal contribution of PGM on the survival of the embryos. The fluorescent and non-fluorescent embryos obtained from every cross were selected separately (100 eggs from each group) and the survival of embryos was calculated as the number of larvae hatching from the eggs within the following two days.
PCR and RTPCR
mRNA was primed with oligo-p(dT) 18 and reverse transcribed by Superscripte II (GIBCO BRL). When cDNA was used as a template and for PCR of small DNA fragments (up to 5 kb), the Qiagen PCR kit was used (201203). Large DNA fragments were amplified using the Expand Long Template PCR kit of Roche (1681834), according the manufacturers' instructions.
The primers used were: for jar mRNA: P1: gagttcgactc gactcatccaac; P517-1: atcacgatgacaactgcgaac; P1027: tagtgcgatatgtaaccaccgacc; TAN: catttccgaattcggcaagatcaa caagatccgg; MYC2: atttaccggtccttgtttctgcattgctgc. For myosin 29D mRNA: TRIF: aatcacagcttcagccacac; 529R: gtcccgacaagtggatcag. For ribosomal RNA: PR491: aagcccaagggtatcgacaac; PR492: attgaactcggcactggcaca. For jar genomic DNA: HKC865F: tgttgctacccattgcttttcaatc; 5k3C865: cgggctgaaaagggaaaag; C865 for: gcggatc caaatcttcttgctttgctg, C865 Rev: tttgaacaggaaactgaaacg, EXC2Rev: acatggaatagggtgcatgg, EXC2For: gtgcttgttgtt tttcgg, mmw14 delfor: tgcaggtgttgcagaagagtg; mmw14delrev: ttatccccttacccctattcc. For jaguar cDNA amplification: MYN: atttccgaattcttcgactcgactcatccaacg; and MYC2.
The PCR products obtained were isolated from Tris-acetate/Ethylenediaminetetra-acetate (TAE) gels, purified, and seqenced.
Antibodies
The Myosin VI monoclonal antibody 3C7 was diluted 1:50 and Myosin VI polyclonal antibody was diluted 1:3. Nonmuscle Myosin II (Edwards and Kiehart, 1996) was diluted 1:50. Phalloidin (molecular probes, A12380) was diluted 1:50, rat anti-Drosophila E-Cadherin (Uemura, T.) was diluted 1:20. Alexafluor 568 conjugated anti mouse (molecular probes) was diluted 1:500, FITC-cojugated anti-mouse IgG and anti rabbit IgG was diluted 1:100. HRP conjugated anti-mouse IgG was diluted 1:500.
For the Western Analysis, 3C7 was diluted 1:200, and the anti-mouse secondary antibody diluted 1:10000. The YP control antibody (Bownes and Nothiger, 1981) was diluted 1:1000 with the HRP conjugated anti-rabbit IgG secondary antibody diluted 1:10000 (Promega).
Western analysis
20 embryos were homogenised in 40 ml of 2 £ loading buffer. Western Blot was performed as described previously .
In situ antibody staining of embryos
Embryos were collected at four hour intervals after laying. They were dechorionated, fixed and devitilinated manually or with methanol. The staining of the embryos was performed according to standard protocols (Sullivan et al., 2000) .
